Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Clinical trial NCT06919159 · COMPLETED

Trial details

NCT number: NCT06919159
Sponsor: Jiequn Yu
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer (Diagnosis)Prostate-specific Membrane Antigen Positron Emission Tomography (PET)

Start date: 2021-07-01
Primary completion: 2022-11-20
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.